According to Gyre Therapeutics's latest financial reports the company's current EPS (TTM) is -1,30 โฌ. In 2023 the company made an earnings per share (EPS) of -1,30 โฌ a decrease over its 2022 EPS that were of 0,004018 โฌ.
Year | EPS | Change |
---|---|---|
2024 (TTM) | 0,09859 โฌ | -107.58% |
2023 | -1,30 โฌ | -32451.8% |
2022 | 0,004018 โฌ | -90.93% |
2021 | 0,04428 โฌ |